Stockreport

The FDA's U-turn on peptides could boost the next telehealth boom [Yahoo! Finance]

Hims & Hers Health, Inc. Class A  (HIMS) 
PDF The FDA is expected to allow compounding pharmacies to produce 14 injectable peptides, in a reversal from its previous ban on the substances, according to a New York Ti [Read more]